Google Colab is a free online tool from Google that lets you write and run Python code directly in your browser.

More employers are seeking candidates with generative AI skills. OpenAI said it's now going to offer certifications for job candidates. The company set a goal to certify 10 million Americans by 2030.

Astronomers and students working together through a unique educational initiative have obtained a striking new image of the growing tail of interstellar Comet 3I/ATLAS. The observations reveal a ...

Sign up for Chalkbeat’s free weekly newsletter to keep up with how education is changing across the U.S. The Trump administration won’t be handing out any blue ...

If you've picked someone up from the airport recently... you may have hit a bit of traffic at the terminal. But the Des Moines airport is trying to make pick-up smoother. The E-Z pick-up program ...

A self-described “MAGA former dancer” is now leading the Kennedy Center’s dance programming, and he’s inherited a series decimated by local boycotts, according to ticket sales data reviewed by ...

Gov. Gavin Newsom speaks about mental health crisis before signing off on two major pieces of legislation to transform the state's mental health system and to address the state's worsening ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Pro-democracy protesters from Eswatini marched on ...

The Please Don’t Destroy boys are being split up on “Saturday Night Live.” “I love these boys so much … This is a new chapter, but we’re not going to stop working together anytime soon,” Marshall ...

Dan Gooding is a Newsweek reporter based in New York City. His focus is reporting on immigration and border security. He has covered immigration issues extensively, including the root causes of ...

Following a review last month, the U.S. Army has canceled its Command Assessment Program, formally established as a program of record in the last days of the Biden administration. Starting in 2019 as ...

Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease. Arrowhead Pharmaceuticals has notched another ...